Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
OTC Markets OTCQB - Delayed Quote USD

Theralase Technologies Inc. (TLTFF)

Compare
0.1300
-0.0005
(-0.38%)
At close: April 4 at 4:00:00 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,033.4310
1,033.4310
1,070.3070
1,138.5690
780.6410
Cost of Revenue
479.4050
479.4050
508.1730
510.3950
470.6980
Gross Profit
554.0260
554.0260
562.1340
628.1740
309.9430
Operating Expense
4,842.3760
4,842.3760
5,156.4000
5,859.7180
4,851.4860
Operating Income
-4,288.3500
-4,288.3500
-4,594.2660
-5,231.5440
-4,541.5430
Net Non Operating Interest Income Expense
42.3160
42.3160
19.4050
9.4120
17.3200
Other Income Expense
-10.0810
-10.0810
3.9810
-13.1700
113.1620
Pretax Income
-4,256.1150
-4,256.1150
-4,570.8800
-5,235.3020
-4,411.0610
Net Income Common Stockholders
-4,256.1140
-4,256.1140
-4,570.8790
-5,235.3020
-4,411.0610
Diluted NI Available to Com Stockholders
-4,256.1140
-4,256.1140
-4,570.8790
-5,235.3020
-4,411.0610
Basic EPS
-0.02
-0.02
-0.02
-0.03
-0.02
Diluted EPS
-0.02
-0.02
-0.02
-0.03
-0.02
Basic Average Shares
232,564.6000
240,068.8390
219,968.3790
207,924.3130
204,275.8750
Diluted Average Shares
232,564.6000
240,068.8390
219,968.3790
207,924.3130
204,275.8750
Rent Expense Supplemental
41.2160
41.2160
41.2160
47.0970
39.5490
Total Expenses
5,321.7810
5,321.7810
5,664.5730
6,370.1130
5,322.1840
Net Income from Continuing & Discontinued Operation
-4,256.1140
-4,256.1140
-4,570.8790
-5,235.3020
-4,411.0610
Normalized Income
-4,246.0330
-4,246.0330
-4,574.8600
-5,222.1320
-4,524.2230
Interest Income
66.4510
66.4510
49.8110
30.6610
22.6620
Interest Expense
24.1350
24.1350
30.4060
21.2490
5.3420
Net Interest Income
42.3160
42.3160
19.4050
9.4120
17.3200
EBIT
-4,231.9800
-4,231.9800
-4,540.4740
-5,214.0530
-4,405.7190
EBITDA
-3,959.8920
-3,959.8920
-4,254.3500
-4,900.8220
-4,129.5690
Reconciled Cost of Revenue
247.1050
247.1050
269.3110
246.0220
271.7060
Reconciled Depreciation
272.0880
272.0880
286.1240
313.2310
276.1500
Net Income from Continuing Operation Net Minority Interest
-4,256.1140
-4,256.1140
-4,570.8790
-5,235.3020
-4,411.0610
Total Unusual Items Excluding Goodwill
-10.0810
-10.0810
3.9810
-13.1700
113.1620
Total Unusual Items
-10.0810
-10.0810
3.9810
-13.1700
113.1620
Normalized EBITDA
-3,949.8110
-3,949.8110
-4,258.3310
-4,887.6520
-4,242.7310
12/31/2021 - 4/5/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SCIE SpectraScience, Inc.
0.0000
0.00%
 
SERA Sera Prognostics, Inc.
3.1900
+1.92%
 
VPT.V Ventripoint Diagnostics Ltd.
0.1500
-6.25%
 
WOK WORK Medical Technology Group LTD
0.4901
-6.65%
 
SNN Smith & Nephew plc
26.31
-5.83%
 
IINN Inspira Technologies Oxy B.H.N. Ltd.
0.5900
-5.39%
 
OPGN OpGen, Inc.
4.0000
-4.76%
 
ATEC Alphatec Holdings, Inc.
10.23
+0.20%
 
ICAD iCAD, Inc.
1.7500
-5.41%
 
SRTS Sensus Healthcare, Inc.
4.4600
-8.98%